- Ongoing, recruitingTherapeutic use (Phase IV)
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
This study is looking at how well insulin eye drops work and if they are safe for people with dry eyes. The main thing they're checking is if the insulin helps improve the surface of the eye over 6 months, compared to normal dry eye treatments.
For: Dry eye diseaseSpain - AuthorisedTherapeutic use (Phase IV)
AliCsa; Efficacy of oral alitretinoin versus oral cyclosporine in patients with moderate to very severe hand eczema. A randomized prospective open-label trial with blinded outcome assessment
This study compares two existing medicines, alitretinoin and ciclosporin, for treating moderate to severe hand eczema. Researchers want to see which one works better and has fewer side effects over 24 weeks. It's for adults with this skin condition.
For: Hand eczemaNetherlands - AuthorisedTherapeutic exploratory (Phase II)
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell Transplantation (allo-SCT) in Acute Myeloid Leukemia (AML) patients (≥40 <65years)
This study is looking at a new way to prepare people with acute myeloid leukaemia (AML) for a stem cell transplant. It's testing a combination of medicines (Fludarabine and Treosulfan) to see if it's safe and effective for adults aged 40 to 65.
For: Acute Myeloid Leukemia (AML)Italy - AuthorisedTherapeutic use (Phase IV)
Safety and efficacy of steering of immunosuppression based on BKPyV-specific T cells in case of BK Polyomavirus (BKPyV) DNAe- mia after kidney transplantation
This study looks at how well a new approach to adjusting medicines helps control a common virus called BK Polyomavirus (BKPyV) in people who have had a kidney transplant. The goal is to find the best way to keep the new kidney healthy.
For: BK Polyomavirus DNAemia after kidney transplantationGermany - AuthorisedTherapeutic use (Phase IV)
Arthritis interception with Guselkumab in subclinical psoriatic arthritis patients in clinical transition from skin to joint disease: a randomized clinical trial.
This study looks at whether a new medicine, Guselkumab, can help people with early signs of psoriatic arthritis (PsA) before it fully develops. It compares Guselkumab with another medicine, Ciclosporin, to see which is better at preventing joint pain and inflammation.
For: PSORIATIC ARTHRITIS PATIENTS IN CLINICAL TRANSITIONItaly